News Releases

Date	Title	Additional Formats
December 11, 2024	Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets
November 7, 2024	Phathom Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
November 4, 2024	Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
October 28, 2024	Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024
October 27, 2024	Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting
August 29, 2024	Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
August 19, 2024	Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants
August 8, 2024	Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
July 30, 2024	Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Commercially Insured Patients
July 29, 2024	Phathom Pharmaceuticals to Report Second Quarter 2024 Financial Results and Provide Business Update on Thursday, August 8, 2024